» Articles » PMID: 15932284

Large-scale Expansion of Mammary Epithelial Stem Cell Aggregates in Suspension Bioreactors

Overview
Journal Biotechnol Prog
Date 2005 Jun 4
PMID 15932284
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in the pathways regulating mammary epithelial stem cell (MESC) self-renewal and differentiation are currently hypothesized to result in uncontrolled cell division and, in turn, breast tumor formation. Although research is aggressively being pursued to understand how such pathways result in breast cancer formation, current studies have been greatly limited by MESC scarcity. To address this issue, this study has successfully developed large-scale expansion protocols for MESC through the subculture of murine mammary epithelial tissue aggregates, called mammospheres, in suspension bioreactors. Growth kinetics of mammospheres cultured in 125 mL suspension bioreactors and T-flasks were found to be comparable, achieving cell densities of 3.10 x 10(5) and 2.75 x 10(5) cells/mL, respectively. This corresponded to a 4-fold expansion over 8 days. Yields were also found to be strongly affected by liquid shear forces, where high agitation rates reduced overall cell numbers. Bioreactor cultures were scaled up to 1000 mL operating volumes, resulting in the production of 4.21 x 10(8) total cells (5.6-fold expansion) from a single passage. Furthermore, intermittent replacement of culture medium with fresh medium dramatically improved maximum cell densities, resulting in an 11-fold expansion, thereby enabling the generation of stem cells in quantities sufficient for standard biochemical and genetic analyses. After being cultured in suspension bioreactors for several passages, analysis by flow cytometry of Ki-67 revealed that 85% of the population was composed of proliferating cells. The successful development of expansion protocols for MESC aggregates in suspension bioreactors makes available experimental avenues that were not previously accessible for breast cancer research, thereby facilitating future investigations into elucidating the role of MESCs in breast cancer tumorigenesis.

Citing Articles

Current status and challenges for cell-cultured milk technology: a systematic review.

Kwon H, Jung H, Kothuri V, Han S J Anim Sci Biotechnol. 2024; 15(1):81.

PMID: 38849927 PMC: 11161985. DOI: 10.1186/s40104-024-01039-y.


Cell Culture Process Scale-Up Challenges for Commercial-Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products.

Lee B, Jung S, Hashimura Y, Lee M, Borys B, Dang T Bioengineering (Basel). 2022; 9(3).

PMID: 35324781 PMC: 8945133. DOI: 10.3390/bioengineering9030092.


The Role of Serotonin in Breast Cancer Stem Cells.

Gwynne W, Shakeel M, Girgis-Gabardo A, Hassell J Molecules. 2021; 26(11).

PMID: 34073226 PMC: 8198186. DOI: 10.3390/molecules26113171.


Organotypic Models in Drug Development "Tumor Models and Cancer Systems Biology for the Investigation of Anticancer Drugs and Resistance Development".

Oliveira E, Goding C, Maria-Engler S Handb Exp Pharmacol. 2020; 265:269-301.

PMID: 32548785 DOI: 10.1007/164_2020_369.


Serum-Free Culture of Human Mesenchymal Stem Cell Aggregates in Suspension Bioreactors for Tissue Engineering Applications.

Allen L, Matyas J, Ungrin M, Hart D, Sen A Stem Cells Int. 2019; 2019:4607461.

PMID: 31814836 PMC: 6878794. DOI: 10.1155/2019/4607461.